Structure of the thrombopoietin-MPL receptor complex is a blueprint for biasing hematopoiesis

Autor(en): Tsutsumi, Naotaka
Masoumi, Zahra
James, Sophie C.
Tucker, Julie A.
Winkelmann, Hauke
Grey, William
Picton, Lora K.
Moss, Lucie
Wilson, Steven C.
Caveney, Nathanael A.
Jude, Kevin M.
Gati, Cornelius
Piehler, Jacob 
Hitchcock, Ian S.
Garcia, K. Christopher
Stichwörter: adult; animal; animal cell; Animals; Article; Bias; bone marrow; c-MPL; CD34 antigen; cell culture; cell cycle; cell expansion; cell proliferation; cell proliferation assay; controlled study; cryo-EM; cryoelectron microscopy; cyclic AMP responsive element binding protein; cytokine receptor; enzyme activation; female; flow cytometry; gene library; genetic variability; genetics; hematology; hematopoiesis; hematopoietic stem cell; hematopoietic stem cell transplantation; homodimerization; human; human cell; Humans; in vitro study; information processing; intracellular signaling; JAK-STAT; Janus kinase; ligand engineering; loss of function mutation; male; megakaryopoiesis; Mice; mitogen activated protein kinase; mouse; MPL protein, human; mTOR; nonhuman; protein engineering; protein function; protein kinase B; protein structure; receptor binding; Receptors, Thrombopoietin; signal transduction; signaling; single cell RNA seq; STAT protein; statistical bias; structure; surface plasmon resonance; thrombocytopenia; thrombocytopoiesis; Thrombopoiesis; thrombopoietin; thrombopoietin receptor; TpoR; umbilical cord blood
Erscheinungsdatum: 2023
Herausgeber: Elsevier B.V.
Journal: Cell
Volumen: 186
Ausgabe: 19
Startseite: 4189 – 4203.e22
Zusammenfassung: 
Thrombopoietin (THPO or TPO) is an essential cytokine for hematopoietic stem cell (HSC) maintenance and megakaryocyte differentiation. Here, we report the 3.4 Å resolution cryoelectron microscopy structure of the extracellular TPO-TPO receptor (TpoR or MPL) signaling complex, revealing the basis for homodimeric MPL activation and providing a structural rationalization for genetic loss-of-function thrombocytopenia mutations. The structure guided the engineering of TPO variants (TPOmod) with a spectrum of signaling activities, from neutral antagonists to partial- and super-agonists. Partial agonist TPOmod decoupled JAK/STAT from ERK/AKT/CREB activation, driving a bias for megakaryopoiesis and platelet production without causing significant HSC expansion in mice and showing superior maintenance of human HSCs in vitro. These data demonstrate the functional uncoupling of the two primary roles of TPO, highlighting the potential utility of TPOmod in hematology research and clinical HSC transplantation. © 2023 The Authors
Beschreibung: 
Cited by: 1; All Open Access, Hybrid Gold Open Access
ISSN: 0092-8674
DOI: 10.1016/j.cell.2023.07.037
Externe URL: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85170209650&doi=10.1016%2fj.cell.2023.07.037&partnerID=40&md5=e9d54cbf577d630f0c4294dd210ce8d9

Zur Langanzeige

Seitenaufrufe

9
Letzte Woche
0
Letzter Monat
2
geprüft am 15.05.2024

Google ScholarTM

Prüfen

Altmetric